The official Opening Plenary of Psychedelic Science 2025. This 90-minute session brings the full community together to mark the start of the conference. No other programming is scheduled during this time—we invite everyone to be part of this collective moment.

After a week of deep learning, connection, and exploration, this final session brings us back together to reflect on where we’ve been and where we’re going.

A growing number of professional athletes are turning to psychedelics, not for performance enhancement, but for healing, reflection, and deeper self-understanding.

Watch for hot-off-the-press public opinion research on Americans’ beliefs, understanding, and policy support around psychedelics.

As interest in psychedelic therapies grows, the conversation needs to shift from promise to practice. This panel brings together voices with unique perspectives to engage with some of the most important questions of the moment.

This special conversation with Dr. Marketa Wills, the new CEO and Medical Director of the American Psychiatric Association, explores the potential for the community and institutions of psychiatry to integrate the findings of the last decade of psychedelic research, and prepare for new therapeutic treatments that may become available in the next few years.

What happens when psychedelic insight meets cosmic data, and sound becomes a tool for transformation? Dr. Scott Bolton, lead scientist on NASA’s Juno Mission, joins Grammy-nominated artists Maejor and Vic Mensa to explore how altered states, planetary frequencies, and spiritual practices shape their creative work.

A lively, fun and freewheeling conversation about psychedelics in creating art and facilitating healing featuring My Morning Jacket lead singer Jim James, and comedian/psychonaut Reggie Watts hosted by writer/producer Donick Cary (The Simpsons, Have a Good Trip: Adventures in Psychedelics)

his opening performance and collective ceremony invites attendees to center and ground themselves in the meaning and purpose of Juneteenth as they move throughout the rest of the conference. Together, we honor the millions harmed by the transatlantic slave trade, and celebrate the still-to-be-realized promise of freedom that Juneteenth represents.

In celebration of Juneteenth, this special opening panel features racial justice activists, criminal and juvenile legal system reform advocates, and visionary leaders in the fight for Black liberation and healing. Panelists will explore socioeconomic and race-based trauma in the US and the role of innovation, Black leadership, and psychedelics in healing that trauma.

As identical twin sisters that experienced sexual, physical, and emotional childhood abuse everyday for over 10 years—and developed identical coping mechanisms that evolved into food addictions—the Quann sisters know firsthand just how seminal psychedelics can be to trauma and healing journeys.

It was not so long ago that psychedelic researchers struggled for public support and alliances. Now, numerous high-profile political leaders are eager to develop psychedelic science programs in their states. In this unique session, we will hear from two sets of scientists and political allies who advocate for expanding psychedelic research in their states.

What if psychedelics could help the brain relearn how to learn? Dr. Gül Dölen shares her groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity.

This special conversation between Oprah Daily Editorial Director Pilar Guzman and Krista Tippett explores the ways in which psychedelics can help women reckon with the cultural constraints around womanhood at every stage of life– but especially its second half.

In this keynote, Dr. Anthony Estreet makes the case social workers are essential to the future of equitable psychedelic care.

In this Keynote we will take a close look at some of the remarkable results of the large Lykos MDMA Study for PTSD which showed that MDMA opens traumatized people up to experience themselves with a deep sense of compassion and kindness.

Paul's talk is a deep dive into psilocybin mushrooms, their past, present and future uses.

Within the last decade, we have witnessed a remarkable shift in cultural perceptions and narratives with respect to psychedelics. Once vilified and prohibited, psychedelics are now being hailed as catalysts for a new revolution in mental health care – even as they remain largely prohibited on the federal level.

Since 2018, ACFH has trained Somali therapists in PTSD treatments, including MDMA-assisted therapy. Supported by MAPS, five therapists participated in MDMA sessions and reported it could help treat trauma in Somaliland. Strong therapist bonds and thorough follow-up are essential. A protocol for community use is in development.

VA researchers Dr. Chris Stauffer and Dr. Amy Lehrner share insights on their pioneering studies of psychedelic-assisted therapy for PTSD, depression, and substance use in veterans, highlighting clinical models, set and setting, and peer support involvement.